ARCHIVES

Cediranib/Olaparib Combination Nearly Doubles PFS in Phase II

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Publishes New Atlas Of Cancer Mortality

December 10, 1999

STI-571 Effects Are Lasting Against GI Stromal Tumors

July 26, 2002

ASCO: NCI Authorities Still Important

June 11, 2010

In Brief: Kennedy Seeing Comments On HAS Regulations; Shimkins History of Cancer Now Available

November 11, 1977

John Mendelson Says M.D. Anderson Plans to Accelerate Role In Translational Research

May 7, 1999

In Brief: Cancer Act Renewal Nears, Appropriations Bills Lag; Interim Funding Likely For ’83 Fiscal Year

September 24, 1982